Absolute Lymphocyte Counts Are Not a Biomarker of Clinical Response in Patients Treated With Delayed-Release Dimethyl Fumarate

被引:0
|
作者
Longbrake, Erin [1 ]
Mao-Draayer, Yang [2 ]
Matthews, Paul M. [3 ]
Foley, John [4 ]
Zielinski, Tomasz [5 ]
Chen, Chongshu [6 ]
Mokliatchouk, Oksana [6 ]
Parks, Becky [6 ]
Sharma, Ankur [6 ]
Xing, Diana [6 ]
Kapadia, Shivani [6 ]
Bame, Eris [6 ]
机构
[1] Yale Univ, New Haven, CT 06520 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[3] Imperial Coll, London, England
[4] Rocky Mt Multiple Sclerosis Clin, Salt Lake City, UT USA
[5] NOVO MED, Katowice, Poland
[6] Biogen, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
830
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study
    Douglas L. Arnold
    Ralf Gold
    Ludwig Kappos
    Amit Bar-Or
    Gavin Giovannoni
    Krzysztof Selmaj
    Minhua Yang
    Ray Zhang
    Monica Stephan
    Sarah I. Sheikh
    Katherine T. Dawson
    Journal of Neurology, 2014, 261 : 2429 - 2437
  • [22] Pregnancy outcomes with delayed-release dimethyl fumarate: preliminary registry results
    Everage, N. J.
    Liu, S.
    Newhook, T.
    Prada, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 347 - 348
  • [23] An interim analysis of quality of life in patients with relapsing-remitting multiple sclerosis treated with delayed-release dimethyl fumarate
    Sarda, S. P.
    Kita, M.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Phillips, T.
    Okwuokenye, M.
    Kong, J.
    Zhang, R.
    Kurukulasuriya, N. C.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 413 - 414
  • [24] Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study
    Arnold, Douglas L.
    Gold, Ralf
    Kappos, Ludwig
    Bar-Or, Amit
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Yang, Minhua
    Zhang, Ray
    Stephan, Monica
    Sheikh, Sarah I.
    Dawson, Katherine T.
    JOURNAL OF NEUROLOGY, 2014, 261 (12) : 2429 - 2437
  • [25] Effect of delayed-release dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis: a retrospective, multicentre, observational study (REALIZE)
    Buckle, G.
    Bandari, D.
    Greenstein, J.
    Gudesblatt, M.
    Khatri, B.
    Kita, M.
    Repovic, P.
    Riser, E.
    Weinstock-Guttman, B.
    Potts, J.
    Everage, N.
    von Hehn, C.
    Mann, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 781 - 782
  • [26] Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS)
    Alroughani, Raed
    Das, Rajiv
    Penner, Natasha
    Pultz, Joe
    Taylor, Catherine
    Eraly, Satish
    PEDIATRIC NEUROLOGY, 2018, 83 : 19 - 24
  • [27] Safety and Efficacy of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice: Interim Analysis of ESTEEM
    Everage, Nicholas J.
    Prada, Claudia
    Liu, Shifang
    Balashov, Konstantin
    Macdonell, Richard
    Windsheimer, Jorg
    Giles, Kathryn
    NEUROLOGY, 2017, 88
  • [28] Safety and efficacy of delayed-release dimethyl fumarate in multiple sclerosis patients treated in routine medical practice: interim analysis of ESTEEM
    Everage, N. J.
    Jones, C. C.
    Das, R.
    Hanna, J.
    Liu, S.
    Balashov, K.
    Macdonell, R.
    Windsheimer, J.
    Giles, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 715 - 716
  • [29] Lymphopenia in Multiple Sclerosis Patients Treated with Delayed-Release Dimethyl Fumarate: Analysis of 2 Electronic Health Record Databases in the US
    Wenten, Made
    Everage, Nicholas
    Somani, Teesta
    Lally, Cathy
    Juneja, Maneesh
    Eaton, Susan
    Prada, Claudia
    Dilley, Anne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 449 - 450
  • [30] Patients treated with delayed-release dimethyl fumarate have no increased risk of herpes zoster based on clinical trial and post-marketing report data
    Hanna, J.
    Prada, C.
    Everage, N.
    Kalari, S.
    Jayia, P.
    Singhal, P.
    Smirnakas, K.
    Englishby, V.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 713 - 714